G-BA procedures on early benefit assessment
Since the AMNOG (Act on the Reform of the Market for Medicinal Products) entered into force on 1 January 2011, a total of 1277 procedures concerning 553 different medicinal products have been initiated by the G-BA. 1174 of these procedures have been finalised with a resolution (see figure). Currently, there are 59 active procedures pursuant to §35a SGB V. Of these, presumably 21 decisions are in preparation, the commenting procedure should be underway for 13 cases, and 25 procedures are listed by the G-BA as initiated. A total of 44 previously initiated procedures were prematurely terminated or postponed by the G-BA.